Clinical Trials Directory

Trials / Sponsors / Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

Industry · 7 registered clinical trials.

StatusTrialPhaseStarted
Active Not RecruitingA Trial of Belzutifan (PT2977, MK-6482) in Combination With Cabozantinib in Patients With Clear Cell Renal Cel
Renal Cell Carcinoma (RCC), Clear Cell Renal Cell Carcinoma (ccRCC), Kidney Cancer
Phase 22018-09-27
Active Not RecruitingA Phase 2 Study of Belzutifan (PT2977, MK-6482) for the Treatment of Von Hippel Lindau (VHL) Disease-Associate
VHL - Von Hippel-Lindau Syndrome, VHL Gene Mutation, VHL Syndrome
Phase 22018-05-02
CompletedA Food Effect Study in Healthy Volunteers With Belzutifan (PT2977, MK-6482) Tablets
Healthy
Phase 12018-02-23
CompletedMK-3795 (PT2385) for the Treatment of Von Hippel-Lindau Disease-Associated Clear Cell Renal Cell Carcinoma (MK
VHL Gene Mutation, VHL, VHL Syndrome
Phase 22017-04-24
Active Not RecruitingA Trial of Belzutifan (PT2977, MK-6482) Tablets In Patients With Advanced Solid Tumors (MK-6482-001)
Advanced Solid Tumors, Solid Tumor, Solid Carcinoma
Phase 12016-12-07
CompletedPT2385-102 Food Effect Study of PT2385 in Healthy Volunteers
Healthy
Phase 12015-09-01
Active Not RecruitingA Phase 1, Dose-Escalation Trial of PT2385 Tablets In Patients With Advanced Clear Cell Renal Cell Carcinoma (
ccRCC, RCC, Kidney Cancer
Phase 12014-11-25